IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Milano.
AIR nasce in UNIMI nel 2006 con lo scopo di raccogliere, documentare e conservare le informazioni sulla produzione scientifica dell'Università degli Studi di Milano e costituisce di fatto l'Anagrafe della ricerca dell'Ateneo.
EnglishBackground HER family receptors play a key role in tumor progression in several malignancies, such as colorectal, lung or breast cancer. The aims of this study were to investigate expression of HER-1, HER-2 and HER-3 in pancreatic cancer (PC) samples and evaluate the association between HER-family receptor expression and patients’ clinical outcomes. Methods Tissue samples from 91 PC patients were subjected to immunohistochemical staining to assess the expression of HER-1, HER-2 and HER-3. Semiquantitative scores of zero (no staining or staining in less than 10% of cancer cells), 1+, 2+ or 3+ were assigned to each sample based on the intensity of staining for HER receptors. Scores of 2+ or 3+ were defined as positive staining. Results HER-1 overexpression was observed in 41 out of 91 samples (45.1%), while HER-2 was not overexpressed in any of the analyzed samples. HER-3 was overexpressed in 37 samples (40.7%) and was found to be associated with advanced TNM stage. In particular, HER-3 was overexpressed in 12 out of 16 stage IV patients (75%) compared with only 33.3% of stage I-III patients (p = 0.02). Among 79 patients with available survival data, the 6 patients with strong HER-3 expression (score 3+) had a shorter survival compared with remaining patients (median overall survival 6.9 months vs. 12.3 months, respectively). Conclusions HER-1 and HER-3 were found to be expressed in a significant proportion of PC patients. Strong HER-3 expression represents an indicator of poor prognosis in PC patients, being associated with advanced stage and shorter survival.
HER family receptor expression and prognosis in pancreatic cancer / A. Bittoni, A. Mandolesi, K. Andrikou, M. Santoni, S. Alfonsi, A. Lanese, C. Loretelli, C. Pellei, F. Piva, M. Scarpelli, S. Cascinu. - In: THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. - ISSN 0393-6155. - 30:3(2015 Jul 01), pp. e327-e332.
| Titolo: | HER family receptor expression and prognosis in pancreatic cancer |
| Autori: | |
| Parole Chiave: | EGFR; HER-2; HER-3; Pancreatic adenocarcinoma; Prognosis; Adenocarcinoma; Aged; Aged, 80 and over; Dimerization; ErbB Receptors; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Proportional Hazards Models; Single-Blind Method; Clinical Biochemistry; Cancer Research; Oncology; 2734; Medicine (all) |
| Settore Scientifico Disciplinare: | Settore MED/06 - Oncologia Medica Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica Settore BIO/13 - Biologia Applicata Settore MED/04 - Patologia Generale Settore MED/03 - Genetica Medica |
| Data di pubblicazione: | 1-lug-2015 |
| Rivista: | |
| Tipologia: | Article (author) |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.5301/jbm.5000157 |
| Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| HER family receptor expression and prognosis in pancreatic cancer.pdf | Publisher's version/PDF | Administrator Richiedi una copia |
Copyright © 2021